Michael Kosteljanetz

3.8k total citations
66 papers, 2.7k citations indexed

About

Michael Kosteljanetz is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Michael Kosteljanetz has authored 66 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 17 papers in Pulmonary and Respiratory Medicine and 12 papers in Neurology. Recurrent topics in Michael Kosteljanetz's work include Glioma Diagnosis and Treatment (22 papers), Brain Metastases and Treatment (12 papers) and Cerebrospinal fluid and hydrocephalus (11 papers). Michael Kosteljanetz is often cited by papers focused on Glioma Diagnosis and Treatment (22 papers), Brain Metastases and Treatment (12 papers) and Cerebrospinal fluid and hydrocephalus (11 papers). Michael Kosteljanetz collaborates with scholars based in Denmark, United States and Netherlands. Michael Kosteljanetz's co-authors include Ulla Feldt‐Rasmussen, Marianne Klose, Hans Skovgaard Poulsen, Carsten Gyldensted, Steinbjørn Hansen, Helle Broholm, Anders Juul, Ulrik Lassen, P. Bjerre and Lars Kristensen and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Neurology.

In The Last Decade

Michael Kosteljanetz

66 papers receiving 2.6k citations

Peers

Countries citing papers authored by Michael Kosteljanetz

Since Specialization

Citations

This map shows the geographic impact of Michael Kosteljanetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kosteljanetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kosteljanetz more than expected).

Fields of papers citing papers by Michael Kosteljanetz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kosteljanetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kosteljanetz. The network helps show where Michael Kosteljanetz may publish in the future.

Co-authorship network of co-authors of Michael Kosteljanetz

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kosteljanetz. A scholar is included among the top collaborators of Michael Kosteljanetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kosteljanetz. Michael Kosteljanetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan 2018 ·Cancer Investigation ·Anders Toft, Thomas Urup, Ib Jarle Christensen, Signe Regner Michaelsen, (unknown), Kirsten Grunnet, Michael Kosteljanetz, Vibeke Andrée Larsen, Ulrik Lassen, Helle Broholm, Hans Skovgaard Poulsen	4
2	Prevalence, birth incidence, and penetrance of von Hippel–Lindau disease (vHL) in Denmark 2016 ·European Journal of Human Genetics ·Marie Louise Mølgaard Binderup, (unknown), Esben Budtz–Jørgensen, Michael Kosteljanetz, Marie Luise Bisgaard	47
3	Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients 2016 ·Molecular Oncology ·Thomas Urup, Signe Regner Michaelsen, Lars Rønn Olsen, Anders Toft, Ib Jarle Christensen, Kirsten Grunnet, Ole Winther, Helle Broholm, Michael Kosteljanetz, Shohreh Issazadeh‐Navikas, Hans Skovgaard Poulsen, Ulrik Lassen	22
4	Von Hippel-Lindau disease (vHL): National clinical guideline for diagnosis and surveillance in Denmark 2013 ·University of Southern Denmark Research Portal (University of Southern Denmark) ·Marie Louise Mølgaard Binderup, Marie Luise Bisgaard, (unknown), Hans Ulrik Møller, Steen Gimsing, Lennart Friis‐Hansen, Thomas van Overeem Hansen, Per Bagi, Ulrich Knigge, Michael Kosteljanetz, Lars Bøgeskov, Carsten Thomsen, Anne‐Marie Gerdes, Lilian Bomme Ousager, Lone Sunde	11
5	Brain perfusion CT compared with 15O-H2O PET in patients with primary brain tumours 2012 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), (unknown), Michael Kosteljanetz, Helle Broholm, Liselotte Højgaard, Ian Law	5
6	Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme 2011 ·Experimental Cell Research ·Marie‐Thérése Stockhausen, Helle Broholm, Mette Villingshøj, Maria Kirchhoff, Tommy Gerdes, (unknown), Michael Kosteljanetz, Mogens Spang‐Thomsen, Hans Skovgaard Poulsen	43
7	Interleukin-8 production from human somatotroph adenoma cells is stimulated by interleukin-1β and inhibited by growth hormone releasing hormone and somatostatin 2011 ·Growth Hormone & IGF Research ·Signe Diness Vindeløv, Marie‐Louise Hartoft‐Nielsen, Åse Krogh Rasmussen, Klaus Bendtzen, Michael Kosteljanetz, Anna‐Maria Andersson, Ulla Feldt‐Rasmussen	16
8	Hypopituitarism is uncommon after aneurysmal subarachnoid haemorrhage 2010 ·Clinical Endocrinology ·Marianne Klose, Jannick Brennum, Lars Poulsgaard, Michael Kosteljanetz, Aase Wagner, Ulla Feldt‐Rasmussen	56
9	Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours 2008 ·Acta Oncologica ·Hans Skovgaard Poulsen, Kirsten Grunnet, Morten Mau‐Sørensen, P. Olsen, Benedikte Hasselbalch, (unknown), Michael Kosteljanetz, Ulrik Lassen	84
10	Adrenocortical insufficiency after pituitary surgery: an audit of the reliability of the conventional short synacthen test 2005 ·Clinical Endocrinology ·Marianne Klose, Martin Lange, Michael Kosteljanetz, (unknown), Ulla Feldt‐Rasmussen	43
11	Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non‐tumour brain tissue 2005 ·Journal of Neurochemistry ·Gitte Petersen, Birthe Moesgaard, Patricia C. Schmid, Harald H.O. Schmid, Helle Broholm, Michael Kosteljanetz, Harald S. Hansen	70
12	Incidences of Gliomas and Meningiomas in Denmark, 1943 to 1997 2003 ·Neurosurgery ·Helle Collatz Christensen, Michael Kosteljanetz, Christoffer Johansen	63
13	Detection of unknown primary tumours in patients with cerebral metastases using whole‐body ¹⁸F‐flouorodeoxyglucose positron emission tomography 2002 ·European Journal of Neurology ·(unknown), Ian Law, Liselotte Højgaard, Michael Kosteljanetz	19
14	Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study¹ 2001 ·The Journal of Clinical Endocrinology & Metabolism ·Jörgen Lindholm, Svend Juul, Jens Otto Lunde Jørgensen, Jens Astrup, P. Bjerre, Ulla Feldt‐Rasmussen, Claus Hagen, Michael Kosteljanetz, Lars Kristensen, Peter Laurberg, Kaare Schmidt, J. Weeke	487
15	Infected ventriculostomy: Bacteriology and treatment 1989 ·Acta Neurochirurgica ·(unknown), (unknown), Tove Ejlertsen, Michael Kosteljanetz	46
16	The Clinical Significance of Straight-Leg Raising (Lasègueʼs Sign) in the Diagnosis of Prolapsed Lumbar Disc 1988 ·Spine ·Michael Kosteljanetz, (unknown), S Schmidt-Olsen	58
17	Clinical evaluation of a simple epidural pressure sensor 1986 ·Acta Neurochirurgica ·Michael Kosteljanetz, S. E. B�rgesen, Pia Stjernholm, Lise Christensen, (unknown), F. Gjerris, (unknown)	16
18	Normal pressure hydrocephalus: Correlation between CT and measurements of cerebrospinal fluid dynamics 1985 ·Acta Neurochirurgica ·Michael Kosteljanetz, (unknown)	20
19	Predictive value of radiculography in patients with lumbago-sciatica a prospective study (part II) 1984 ·Acta Neurochirurgica ·J. O. Espersen, Michael Kosteljanetz, (unknown), (unknown)	7
20	Predictive value of clinical and surgical findings in patients with lumbago-sciatica 1984 ·Acta Neurochirurgica ·Michael Kosteljanetz, J. O. Espersen, (unknown), (unknown)	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact